SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nagaraju R. Arakotaram who wrote ()4/5/1996 4:36:00 PM
From: Carlos Fung   of 1510
 
Nagaraju, I have traded immune response for over 2-3 years.
When it was around $6 and when it went as high as $50 (when the Biotechs were hot, in the good old days). I have bought and sold the stock many times and I finally got rid of my last shares yesterday. They have been in alot of Phase II and Phase III stages on most of their products and from reading their quarter and annual reports they have not been making money yet. I was glad that it went up on Tuesday, I think there were alot of profit takers yesterday or maybe alot of the old investors were trying to get rid of their old shares, like I did. I love the company and I am going to back to it when it gets around $7-$8. If you can wait for their products to get past clinical stages, I can see the stock going as high as $20 in a year and maybe over $30 next year. The stock has been trading back and forth (before Tuesday's news) around $5.5 - $8.5 for over a year, which is a pretty good % return if you buy enough shares !
Good luck, and I waiting to get back in.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext